NFKB1 and cancer: It can suppress the activation of multiple oncogenic pathways, including PI3K/Akt, MAPK, NF-κB, Wnt/β-catenin, and JAK-STAT, resulting in reduced cancer cell proliferation, cell cycle arrest, and induction of apoptosis [38,39].